Of interest, adipose tissue-derived IL-6 was shown to induce hepatic IR and inflammation [196], contrary to muscle-derived IL-6, which was shown to improve IR in mice and human NAFLD [197, 198]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.